Reply to 'SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?'
Int J Infect Dis
.
2020 Dec:101:57.
doi: 10.1016/j.ijid.2020.09.1461.
Epub 2020 Sep 28.
Authors
Sergio Bagnato
1
,
Cristina Boccagni
2
,
Giorgio Marino
3
,
Caterina Prestandrea
4
,
Tiziana D'Agostino
5
,
Francesca Rubino
6
Affiliations
1
Rehabilitation Department, Giuseppe Giglio Foundation, Viale Giuseppe Giardina, 90015 Cefalù, PA, Italy. Electronic address: sergiobagnato@gmail.com.
2
Rehabilitation Department, Giuseppe Giglio Foundation, Viale Giuseppe Giardina, 90015 Cefalù, PA, Italy. Electronic address: cristina.boccagni@hsrgiglio.it.
3
Rehabilitation Department, Giuseppe Giglio Foundation, Viale Giuseppe Giardina, 90015 Cefalù, PA, Italy. Electronic address: giorgio.marino@hsrgiglio.it.
4
Rehabilitation Department, Giuseppe Giglio Foundation, Viale Giuseppe Giardina, 90015 Cefalù, PA, Italy. Electronic address: caterina.prestandrea@gmail.com.
5
Rehabilitation Department, Giuseppe Giglio Foundation, Viale Giuseppe Giardina, 90015 Cefalù, PA, Italy. Electronic address: dagostinotiziana@gmail.com.
6
Rehabilitation Department, Giuseppe Giglio Foundation, Viale Giuseppe Giardina, 90015 Cefalù, PA, Italy. Electronic address: francesca.rubino@hsrgiglio.it.
PMID:
33002615
DOI:
10.1016/j.ijid.2020.09.1461
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Critical Illness
Humans
Muscular Diseases*
Myotoxicity
Pandemics
SARS-CoV-2